View More Recent Stories

Feb 21, 2025 06:08AM Glaukos Corporation (GKOS) PT Raised to $176 at Needham

Feb 21, 2025 05:08AM Glaukos Corporation (GKOS) PT Lowered to $155 at BTIG

Feb 20, 2025 04:15PM Glaukos Corporation (GKOS) Misses Q4 EPS by 2c, Beats on Revenue; Offers FY25 Revenue Guidance

Feb 17, 2025 09:31AM Truist on Glaukos Corporation (GKOS): 'Survey Supports Bull Case (Or Better) Upside Scenarios'

Jan 27, 2025 07:36AM Piper Sandler's KOL Calls iDose a 'Game-Changer'; Glaukos Corporation (GKOS) PT Raised to $180

Jan 21, 2025 06:00PM MedTech sector outlook for 2025: Truist Securities

Jan 14, 2025 04:06PM Glaukos Corporation (GKOS) Announces Positive Clinical Updates for its iDose Sustained-Release Procedural Pharmaceutical Platform

Dec 30, 2024 11:32PM Glaukos Corporation (GKOS) PT Raised to $175 at Stifel

Dec 23, 2024 07:05AM Glaukos Corporation (GKOS) Submits New Drug Application to U.S. FDA for Epioxa

Dec 19, 2024 08:17AM Medical Technology and Devices: Piper Sandler Shares 'Quick Thoughts on HC Conference in Jan'

Dec 17, 2024 06:47AM Glaukos Corporation (GKOS) PT Raised to $140 at Mizuho

Dec 11, 2024 05:13AM Citi Upgrades Glaukos Corporation (GKOS) to Buy

Dec 6, 2024 03:47AM UBS Starts Glaukos Corporation (GKOS) at Buy

Dec 2, 2024 07:52AM Glaukos Corporation (GKOS) PT Raised to $153 at Stifel

Dec 2, 2024 06:26AM Morgan Stanley Downgrades Glaukos Corporation (GKOS) to Underweight

Nov 5, 2024 07:14AM Piper Sandler Reiterates Overweight Rating on Glaukos Corporation (GKOS)

Nov 5, 2024 06:08AM Needham Reiterates Buy Rating on Glaukos Corporation (GKOS)

Nov 5, 2024 05:12AM Glaukos Corporation (GKOS) PT Raised to $140 at BTIG

Nov 4, 2024 04:15PM Glaukos Corporation (GKOS) Tops Q3 EPS by 20c, provides guidance

Oct 29, 2024 06:09AM Glaukos Corporation (GKOS) PT Raised to $155 at Jefferies

Oct 21, 2024 08:34AM Truist Securities Reiterates Buy Rating on Glaukos Corporation (GKOS)

Oct 17, 2024 07:51AM Piper Sandler Reiterates Overweight Rating on Glaukos Corporation (GKOS)

Oct 16, 2024 04:05PM Glaukos Corporation (GKOS) Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa

Sep 26, 2024 07:56AM BTIG Reiterates Buy Rating on Glaukos Corporation (GKOS)

Sep 23, 2024 05:09AM BTIG Reiterates Buy Rating on Glaukos Corporation (GKOS)

Sep 3, 2024 08:17AM Glaukos Corporation (GKOS) PT Raised to $145 at Stifel

Aug 1, 2024 07:42AM Glaukos Corporation (GKOS) PT Raised to $140 at Piper Sandler

Aug 1, 2024 07:22AM Glaukos Corporation (GKOS) PT Raised to $137 at Needham

Aug 1, 2024 06:05AM Glaukos Corporation (GKOS) PT Raised to $145 at Truist Securities

Jul 31, 2024 04:29PM Glaukos Corporation (GKOS) Reports In-Line Q2 EPS, Beats on Revenue; Offers FY24 Revenue Guidance

Jul 16, 2024 07:06AM Glaukos Corporation (GKOS) PT Raised to $141 at Truist Securities

Jul 15, 2024 06:38AM Glaukos Corporation (GKOS) PT Raised to $115 at Mizuho

Jul 15, 2024 04:00AM MedTech stocks: Q2 earnings season preview

Jun 14, 2024 07:01AM Glaukos Corporation (GKOS) to Exchange $230M in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock

Apr 13, 2024 08:00AM Analyst weighs in on current investor sentiment in MedTech sector

View More Recent Stories